Article
A novel (288delC) mutation in exon 2 of GPIIb associated with type I Glanzmann's thrombasthenia.
Department of Pathophysiology and Human Molecular Genetics, Centro de Investigaciones Biológicas, Madrid, Spain.
British Journal of Haematology (impact factor:
4.94).
11/2000;
111(1):96-103.
pp.96-103
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Type II Glanzmann thrombasthenia in a compound heterozygote for the alpha IIb gene. A novel missense mutation in exon 27.
[show abstract] [hide abstract]
ABSTRACT: Glanzmann thrombasthenia is an autosomal recessive bleeding disorder characterized by a life-long hemorrhagic tendency and absent or severely reduced platelet aggregation in response to agonists, caused by quantitative or qualitative abnormalities in the platelet fibrinogen receptor, integrin alphaIIb beta3. The aim of this study was to identify the molecular genetic defect and determine its functional consequences in a patient with type II Glanzmann thrombasthenia. The expression of platelet alphaIIb beta3 was determined by flow cytometry and western blotting. Mutations were identified by sequencing both cDNA and genomic DNA. Functional characterization was assessed by exontrap and transient transfection analysis. Flow cytometry and western blot analysis revealed markedly reduced levels of platelet alphaIIb beta3, which may account for the residual fibrinogen binding detected upon platelet activation. Sequencing of genomic DNA revealed the presence of two mutations in the alphaIIb gene: a C1750T transition in the last codon of exon 17 changing Arg553 to STOP, and a C2829T transition in exon 27 that changes Pro912 to Leu. Sequence analysis of reversely transcribed alphaIIb mRNA did not detect cDNA from the C1750T mutant allele, and revealed a significant increase of the physiological splicing out of exon 28 in the cDNA carrying the C2829T mutation. Transient expression of [912Leu]alphaIIb in CHO-b3 cells showed a marked reduction in the rate of surface expression of alphaIIb beta3. The results suggest that the thrombasthenic phenotype is the result of reduced availability of alphaIIb-mRNA, enhanced expression of exon 28-deleted transcripts, and defective processing of [912Leu]alphaIIb.Haematologica 11/2006; 91(10):1352-9. · 6.42 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
cDNAs encoding GPIIIa
Chinese hamster ovary
clinical diagnosis
exon 2
exons 2
Glanzmann's thrombasthenia
GP)IIb-IIIa complexes
GPIIb mRNA
GPIIb-IIIa complexes
homozygous deletion
molecular genetic analysis
mucocutaneous haemorrhages
platelet surface glycoprotein
Polymerase chain reaction single-strand conformation polymorphism
premature termination codon
surface exposure
surface expression
thrombasthenic phenotype
translation start site
work reports